Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Cosmetic – antiperspirant – dentifrice
Patent
1994-02-16
1997-01-07
Azpuru, Carlos A.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Cosmetic, antiperspirant, dentifrice
424 45, 424 851, 424 852, 424426, 424434, 424435, 424489, 424499, 424501, 514885, A61K 914, A61F 202, A61L 904
Patent
active
055914411
ABSTRACT:
A non-specific host immune cell augmentation composition for enhanced microorganism killing utilizes any phagocytosable, biocompatible particle to prime macrophages for enhanced oxidative response and bacterial killing. Patients can have the benefits of primed macrophages in one to four days, and experiments have demonstrated over a 100-fold increase in oxidative potential within this time period. The oxidative response and killing potential is non-immunospecific, meaning not one organism, not a vaccine, and broadly applicable simultaneously to bacteria and viruses as well as tumor cells. The effects have been demonstrated to have a seven day duration to have a seven day duration indicating non-tissue toxic residual effects and potential for repeated use at monthly intervals.
REFERENCES:
patent: 4707471 (1987-11-01), Larm et al.
patent: 4783484 (1988-11-01), Violanto et al.
patent: 4795745 (1989-01-01), Larm et al.
patent: 4826689 (1989-05-01), Violanto et al.
patent: 4900722 (1990-02-01), Williams et al.
patent: 4971801 (1990-11-01), Urban
patent: 5004604 (1991-04-01), Terness et al.
patent: 5045320 (1991-09-01), Mescher
patent: 5078996 (1992-01-01), Conlon et al.
patent: 5091511 (1992-02-01), Sone et al.
Kingo Chida et al., Chemiluminescent Response of Alveolar Macrophages, Infect. Immun., vol. 55, No. 6, Jun. 1987.
Hiroshi Hayakawa et al., Oxidative Responses of Rabbit Alleolar Macrophages, J. of Leukocyte Biology, 45 (1989).
Q. N. Myrvik et al., S.epidermidis Slime and Alveolar Macrophages, Journal of Investigative Surgery, vol. 2.
Keiko Umehara et al., L-Fucose Blocks MIF/MAF Priming, Cellular Immunology 119, (1989).
G. Giridhar et al., HSV-2 Infection and CL Response in Rabbit AM, Journal of Leukocyte Biology 49:442-448 (1991).
A. Bautista et al., In vivo latex phagocytosis primes . . ., Journal of Leukocyte Biology, vol. 51, Jan. 1992.
K. E. Driscoll et al., Release of Interleukin-1 and Tumor Necrosis . . ., NATO ASI Series vol. H30.
K. Donaldson et al., Release of Superoxide Anion and Hydrogen Peroxide . . ., NATO ASI Series, vol. G3.
Rolf Seljelid, Immunomodulator-Medicine for the 90-ies?, Immunomodulators, pp. 107-113.
Hiroshi Hayakawa et al., Pulmonary Surfactant Phospholipids Modulate . . ., Journal of Leukocyte Biology.
Bernard M. Babior et al., Oxygen-Dependent Microbial Killing by Phagocytes, New England Journal of Medicine.
Seymour J. Klebanoff, Oxgen-Dependent Cytotoxic Mechanisms of Phagocytes, Adv.in Host Defense Mechanisms.
K. Donaldson et al., Chemiluminescence of asbestos-activated macrophages, Br.J.exp.Path.(1984) 65, pp. 81-90.
Gristina Anthony G.
Myrvik Quentin N.
Azpuru Carlos A.
Medical Sciences Research Institute
LandOfFree
Composition for nonspecific cellular immune stimulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for nonspecific cellular immune stimulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for nonspecific cellular immune stimulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1762315